![]() |
市場調查報告書
商品編碼
1494603
胃腸道設備市場:按產品、適應症和最終用戶分類 - 全球預測 2024-2030Gastrointestinal Devices Market by Product, Indication, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
胃腸道設備市場規模預計2023年為75.4億美元,預計2024年將達到81.1億美元,2030年將達到126.5億美元,複合年成長率為7.67%。
胃腸道設備是用於診斷、治療和管理胃腸道和消化器官系統疾病的醫療設備。包括內視鏡、切片檢查裝置、支架及腸道餵食幫浦等設備。隨著世界人口老化,大腸直腸癌、胃食道逆流(GERD)等常見影響老年人的胃腸道疾病數量不斷增加,診斷和治療的需求不斷增加。隨著越來越多的政府和個人優先考慮醫療保健,醫療保健基礎設施(包括先進的醫療設備)的投資和資金籌措不斷增加,以實現更好的疾病管理。然而,胃腸道設備,尤其是那些技術先進的胃腸道設備,操作起來可能很複雜,需要大量的培訓和專業知識,並且並非在所有醫療機構中都容易獲得。適當的維護和嚴格的滅菌通訊協定對於避免感染並確保病人和醫護人員的安全至關重要,任何疏忽都可能導致嚴重的健康風險。人工智慧和機器學習的結合可以提高胃腸設備的診斷能力,從而實現更準確、更有效率的患者照護。開發提供更強連接和遠端監控功能的設備來幫助管理慢性胃腸道疾病可以改善患者的治療效果並減少就診次數。
主要市場統計 | |
---|---|
基準年[2023] | 75.4億美元 |
預測年份 [2024] | 81.1億美元 |
預測年份 [2030] | 126.5億美元 |
複合年成長率(%) | 7.67% |
區域洞察
以美國和加拿大為中心的美洲地區由於其先進的醫療基礎設施和主要設備製造商的強大影響力,代表了胃腸道設備的強勁市場環境。美洲消費者的需求是由對微創手術的偏好所驅動的,這種手術可以提供更快的恢復時間和更短的住院時間。該地區最近的專利專注於提高診斷能力和患者舒適度,包括創新的內視鏡攝影機和新的支架材料。投資正在積極進行,並正在進行研究以開發更精確、侵入性更小的技術。歐盟國家代表著一個多元化的市場,廣泛接受先進的醫療技術,並擁有強調病人安全和有效性的強力的法規結構。這裡的重點是改善老齡化社會的生活品質,導致結腸鏡和膠囊內視鏡等胃腸設備的持續引入。歐盟透過「地平線歐洲」等框架積極促進醫療保健研究,特別是促進個人化醫療和非侵入性治療的創新。由於政府旨在提供全面健康保險和促進本地製造的醫療改革,亞太地區的胃腸道設備市場正在迅速擴大。消費者正在接受新的胃腸道治療技術。地方創新得到大規模、國家資助的研究計畫的支持,旨在開發更便宜的診斷設備和治療方法。
FPNV定位矩陣
FPNV 定位矩陣對於評估胃腸道設備市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對胃腸道設備市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在胃腸道設備市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[195 Pages Report] The Gastrointestinal Devices Market size was estimated at USD 7.54 billion in 2023 and expected to reach USD 8.11 billion in 2024, at a CAGR 7.67% to reach USD 12.65 billion by 2030.
Gastrointestinal devices are medical tools used to diagnose, treat, and manage disorders of the gastrointestinal tract and digestive system. These include a range of instruments such as endoscopes, biopsy devices, stents, and enteral feeding pumps. As the global population ages, there is an increase in gastrointestinal conditions that typically affect older adults, such as colorectal cancer and gastroesophageal reflux disease (GERD), driving the need for diagnostic and therapeutic gastrointestinal devices. As more governments and individuals prioritize healthcare, there is increased investment and funding in healthcare infrastructures, including advanced medical devices, for better disease management. However, gastrointestinal devices, especially those that are technologically advanced, can be complex to operate, requiring extensive training and expertise, which might not be readily available in all healthcare settings. Proper maintenance and strict sterilization protocols are critical to avoid infections and ensure the safety of both patients and healthcare providers, and any lapses can lead to serious health risks. Incorporating artificial intelligence and machine learning can enhance the diagnostic capabilities of gastrointestinal devices, leading to more precise and efficient patient care. Developing devices that offer better connectivity and remote monitoring capabilities to assist in the management of chronic gastrointestinal conditions can improve patient outcomes and reduce hospital visits.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.54 billion |
Estimated Year [2024] | USD 8.11 billion |
Forecast Year [2030] | USD 12.65 billion |
CAGR (%) | 7.67% |
Regional Insights
The Americas region, particularly the U.S. and Canada, represents a robust landscape for gastrointestinal devices due to its advanced healthcare infrastructure and strong presence of major device manufacturers. Consumer needs in the Americas region are driven by the preference for minimally invasive procedures offering quicker recovery times and reduced hospital stays. Recent patents in the region have focused on improving diagnostic capabilities and patient comfort, such as innovative endoscopic cameras and new materials for stents. Investments are robust, often channeled into research for developing more precise and less invasive technologies. EU countries exhibit a diverse market with widespread acceptance of advanced medical technologies due to strong regulatory frameworks that emphasize patient safety and efficacy. The focus here is on enhancing the quality of life of the aging population, leading to a sustained adoption of gastrointestinal devices such as colonoscopes and capsule endoscopy devices. The EU's active promotion of healthcare research through frameworks such as Horizon Europe fosters innovation, particularly in personalized medicine and non-invasive treatments. APAC's market for gastrointestinal devices is rapidly expanding due to robust governmental health reforms aimed at providing comprehensive health insurance coverage and boosting local manufacturing. Consumers are increasingly accepting new gastrointestinal treatment technologies. Local innovation is supported by significant state-funded research initiatives aimed at developing less costly diagnostic devices and treatments.
Market Insights
The market dynamics represent an ever-changing landscape of the Gastrointestinal Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Gastrointestinal Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Gastrointestinal Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fujifilm Introduces Tracmotion ESD Device at Endocon 2024
Fujifilm unveiled its newest endoscopic device, Tracmotion, at Endocon 2024 in Delhi, a key event in gastroenterology advancements. Tracmotion, which has received the red dot award, enhances the endoscopic submucosal dissection (ESD) process, a vital, minimally invasive procedure used to remove precancerous and cancerous lesions in the gastrointestinal tract. The device enables a more precise and effective treatment by allowing surgeons to target and remove lesions while preserving healthy tissue, thereby facilitating early intervention in gastrointestinal diseases. [Published On: 2024-04-23]
FDA Grants De Novo Clearance to AnX Robotica's AI-assisted Endoscopy Tool, NaviCam ProScan
AnX Robotica, a U.S.-based manufacturing firm, has obtained de novo clearance from the FDA for its innovative tool, NaviCam ProScan. This advanced AI-assisted endoscopy device leverages convolutional neural networks (CNNs) to enhance diagnostic capabilities. Specifically, it employs deep learning to distinguish between healthy tissue and abnormal lesions during endoscopic procedures, promising significant improvements in the accuracy and efficiency of gastrointestinal diagnosis. [Published On: 2024-01-03]
Medtronic and Cosmo Amplify AI-Driven Endoscopy Collaboration with Expanded Partnership
Medtronic has committed USD 100 million upfront to enhance its exclusive global distribution agreement with Cosmo Intelligent Medical Devices, focusing on the GI Genius platform. GI Genius, which obtained de novo clearance in 2021, integrates machine learning to assist in identifying potential lesions during colonoscopies by marking areas of interest, aiding physicians in spotting polyps or suspected tumors more effectively. This extension of the collaboration underscores the integration of advanced technology in gastrointestinal diagnostics and the commitment to improving detection capabilities. [Published On: 2023-12-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Gastrointestinal Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Gastrointestinal Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Kasei Medical Co., Ltd., Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Getinge AB, Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Leo Medical Co.,Ltd., Medtronic plc, Merit Medical Systems, Inc., Micro-Tech (Nanjing) Co., Ltd., Olympus Corporation, Ovesco Endoscopy AG, Pentax Medical by HOYA Corporation, Prion Medical BV, Richard Wolf GmbH, Siemens Healthineers AG, Smith+Nephew, STERIS Corporation, Stryker Corporation, Teleflex Incorporated, and W. L. Gore & Associates, Inc..
Market Segmentation & Coverage